Among others, the contribution of PTEN deletion to prostate cancer tumorigenesis and progression was underlined in a large study that incorporated more than 4.5 thousand specimens and correlated its presence to advanced tumor stages, higher Gleason score grades, positive lymph nodes and androgen-independent disease, linking it to an overall aggressive tumor phenotype [12]. This evidence concerns the gene PTEN and Familial prostate cancer.